Related Experiment Videos

[Infectious endocarditis in mitral valve prolapse]

C Ginghină1, C Carp, D Rogozea

  • 1Clinica de Cardiologie, Spitalul Clinic Fundeni, Bucureşti.

Revista De Medicina Interna, Neurologe, Psihiatrie, Neurochirurgie, Dermato-Venerologie. Medicina Interna
|January 1, 1990
PubMed

Insights

Infectious endocarditis in patients with mitral valve prolapse is uncommon but serious. Prompt antibiotic treatment can heal infections, often avoiding surgery for endocarditis itself.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Valvular Heart Disease

Context:

  • Prolapse of the mitral valve (MVP) is a common valvular heart condition.
  • Infectious endocarditis (IE) is a serious complication that can affect patients with MVP.
  • This study analyzed 13 cases of IE in MVP patients over a decade.

Purpose:

  • To analyze the clinical presentation, diagnostic findings, treatment, and outcomes of infectious endocarditis in patients with mitral valve prolapse.
  • To determine the incidence of IE in MVP patients and its impact on valvular function.
  • To evaluate the necessity of surgical intervention for IE in this patient population.

Summary:

  • All 13 MVP patients with IE had positive blood cultures, predominantly viridans streptococci.
  • Echocardiography revealed valvular vegetations in 41.15% and chordal rupture in 15.38% of cases.
  • Antibiotic therapy successfully treated the infection in all cases, with surgery reserved for persistent mitral regurgitation.

Impact:

  • Antibiotic treatment effectively resolved infectious endocarditis in all analyzed cases.
  • Surgery was not required during the active infection phase but was performed later for significant mitral regurgitation.
  • Prophylaxis against infectious endocarditis is crucial for patients with mitral valve prolapse and mitral regurgitation.

Related Concept Videos